全球口服祛痰药市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

全球口服祛痰药市场预测将大幅成长，预计到 2033 年市场规模将飙升至 67.8 亿美元，较 2024 年的 49 亿美元大幅成长。这一扩张反映了 2025 年至 2033 年期间预计 3.68% 的惊人年复合成长率(CAGR)。

受支气管炎、慢性阻塞性肺病 (COPD) 和普通感冒等呼吸系统疾病日益流行的推动，全球口服祛痰药市场有望稳步增长。祛痰药有助于清除黏液，改善呼吸功能，提升患者舒适度。未来的发展将着重于研发疗效更佳、副作用更少、天然成分更丰富的新型製剂。

此外，空气污染和吸烟率的上升加剧了呼吸系统健康挑战，扩大了市场需求。非处方药 (OTC) 的成长和自我药疗趋势正在扩大消费者的可近性。包括缓释和联合疗法在内的药物传输技术的进步正在改善治疗效果。随着呼吸照护的发展，口服祛痰药市场将持续创新，提供安全、有效且病人友善的解决方案。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：口服祛痰药 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按药物类型分析市场吸引力
  • 按剂型分析市场吸引力
  • 药物市场吸引力分析
  • 按配销通路分析市场吸引力
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球口服祛痰药市场分析：依药物类型

• 依药物类型概览
• 按药物类型进行的历史和预测数据分析
• 分泌促进剂
• 黏液溶解剂

第六章：全球口服祛痰药市场分析：按剂型

• 按剂型概述
• 以剂型分析历史和预测数据
• 口服固体製剂
• 口服液
• 吸入剂

第七章：全球口服祛痰药市场分析：依药物

• 药物概述
• 按药物进行的历史和预测数据分析
• 处方药
• 非处方药

第 8 章：全球口服祛痰药市场分析：依通路

• 按配销通路概览
• 按配销通路进行历史和预测资料分析
• 医院药房
• 零售店和药局

第九章：全球口服祛痰药市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 10 章：口服祛痰药公司的竞争格局

• 口服祛痰药市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Abbott Laboratories
• 公司概况
• 公司收入
• 产品
• 最新动态
• AstraZeneca
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cipla Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Genexa Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• GlaxoSmithKline (GSK) Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck KGaA
• 公司概况
• 公司收入
• 产品
• 最新动态
• Perrigo Company Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Reckitt Benckiser Group PLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sanofi
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sun Pharmaceutical Industries Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• The Himalaya Drug Company
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

The forecast for the global Oral Expectorant market predicts substantial growth, with market size projected to soar to USD 6.78 Billion by 2033, a significant increase from the USD 4.9 Billion recorded in 2024. This expansion reflects an impressive compound annual growth rate (CAGR) of 3.68% anticipated between 2025 and 2033.

The global oral expectorant market is set for steady growth driven by increasing prevalence of respiratory diseases such as bronchitis, chronic obstructive pulmonary disease (COPD), and common cold. Expectorants facilitate mucus clearance, improving respiratory function and patient comfort. Future developments will focus on novel formulations with enhanced efficacy, reduced side effects, and natural ingredient integration.

Additionally, rising air pollution and smoking rates are contributing to respiratory health challenges, expanding market demand. The growth of over-the-counter (OTC) products and self-medication trends is broadening consumer access. Advances in drug delivery technologies, including sustained-release and combination therapies, are improving treatment outcomes. As respiratory care evolves, the oral expectorant market will continue to innovate, delivering safe, effective, and patient-friendly solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Oral Expectorant market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

• Secretion Enhancer
• Mucolytics

By Dosage Form

• Oral Solids
• Oral Liquids
• Inhalants

By Medication

• Prescription Drugs
• Over-The-Counter Drugs

By Distribution Channel

• Hospital Pharmacies
• Retail Store & Drug Store
• List of Companies Profiled in the report
• Abbott Laboratories, AstraZeneca, Cipla Inc., Genexa Inc., GlaxoSmithKline (GSK) plc, Merck KGaA, Perrigo Company plc, Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Ltd., The Himalaya Drug Company.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ORAL EXPECTORANT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Type
  • 3.7.2 Market Attractiveness Analysis By Dosage Form
  • 3.7.3 Market Attractiveness Analysis By Medication
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ORAL EXPECTORANT MARKET ANALYSIS BY DRUG TYPE

• 5.1. Overview By Drug Type
• 5.2. Historical and Forecast Data Analysis By Drug Type
• 5.3. Secretion Enhancer Historic and Forecast Sales By Regions
• 5.4. Mucolytics Historic and Forecast Sales By Regions

6. GLOBAL ORAL EXPECTORANT MARKET ANALYSIS BY DOSAGE FORM

• 6.1. Overview By Dosage Form
• 6.2. Historical and Forecast Data Analysis By Dosage Form
• 6.3. Oral Solids Historic and Forecast Sales By Regions
• 6.4. Oral Liquids Historic and Forecast Sales By Regions
• 6.5. Inhalants Historic and Forecast Sales By Regions

7. GLOBAL ORAL EXPECTORANT MARKET ANALYSIS BY MEDICATION

• 7.1. Overview By Medication
• 7.2. Historical and Forecast Data Analysis By Medication
• 7.3. Prescription Drugs Historic and Forecast Sales By Regions
• 7.4. Over-The-Counter Drugs Historic and Forecast Sales By Regions

8. GLOBAL ORAL EXPECTORANT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data Analysis By Distribution Channel
• 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 8.4. Retail Store & Drug Store Historic and Forecast Sales By Regions

9. GLOBAL ORAL EXPECTORANT MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ORAL EXPECTORANT COMPANIES

• 10.1. Oral Expectorant Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF ORAL EXPECTORANT INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Abbott Laboratories
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. AstraZeneca
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Cipla Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Genexa Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. GlaxoSmithKline (GSK) Plc
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Merck KGaA
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Perrigo Company Plc
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Reckitt Benckiser Group PLC
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Sanofi
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Sun Pharmaceutical Industries Ltd.
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. The Himalaya Drug Company
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Drug Type (USD MN)
• Secretion Enhancer Market Sales By Geography (USD MN)
• Mucolytics Market Sales By Geography (USD MN)
• Analysis By Dosage Form (USD MN)
• Oral Solids Market Sales By Geography (USD MN)
• Oral Liquids Market Sales By Geography (USD MN)
• Inhalants Market Sales By Geography (USD MN)
• Analysis By Medication (USD MN)
• Prescription Drugs Market Sales By Geography (USD MN)
• Over-The-Counter Drugs Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Store & Drug Store Market Sales By Geography (USD MN)
• Global Oral Expectorant Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Oral Expectorant Report
• Market Research Process
• Market Research Methodology
• Global Oral Expectorant Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Drug Type
• Market Attractiveness Analysis By Dosage Form
• Market Attractiveness Analysis By Medication
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Drug Type (USD MN)
• Secretion Enhancer Market Sales By Geography (USD MN)
• Mucolytics Market Sales By Geography (USD MN)
• Global Market Analysis By Dosage Form (USD MN)
• Oral Solids Market Sales By Geography (USD MN)
• Oral Liquids Market Sales By Geography (USD MN)
• Inhalants Market Sales By Geography (USD MN)
• Global Market Analysis By Medication (USD MN)
• Prescription Drugs Market Sales By Geography (USD MN)
• Over-The-Counter Drugs Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Store & Drug Store Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.